FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3094136275> ?p ?o ?g. }

• W3094136275 abstract "Abstract Knowledge of the sensitivities of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibody tests beyond 35 days after the clinical onset of COVID-19 is insufficient. We aimed to describe positivity rate of SARS-CoV-2 assays employing three different measurement principles over a prolonged period. Two hundred sixty-eight samples from 180 symptomatic patients with COVID-19 and a reverse transcription polymerase chain reaction (RT-PCR) test followed by serological investigation of SARS-CoV-2 antibodies were included.. We conducted three chemiluminescence (including electrochemiluminscence, ECLIA), four enzyme linked immunosorbent assay (ELISA), and one lateral flow immunoassay (LFIA) test formats. Positivity rates, as well as positive (PPV) and negative predictive values (NPV) were calculated for each week after the first clinical presentation for COVID-19. Furthermore, combinations of tests were assessed within an orthogonal testing approach employing two independent assays and predictive values were calculated. Heat maps were constructed to graphically illustrate operational test characteristics. During a follow-up period of more than 9 weeks, chemiluminescence assays and one ELISA IgG test showed stable positivity rates after the third week. With the exception of ECLIA, the PPVs of the other chemiluminescence assays were ≥95% for COVID-19 only after the second week. ELISA and LFIA had somewhat lower PPVs. IgM exhibited insufficient predictive characteristics. An orthogonal testing approach provided PPVs ≥95% for patients with a moderate pretest probability (e.g., symptomatic patients), even for tests with a low single test performance. After the second week, NPVs of all but IgM assays were ≥95% for patients with low to moderate pretest probability. The confirmation of negative results using an orthogonal algorithm with another assay provided lower NPVs than the single assays. When interpreting results from SARS-CoV-2 tests, the pretest probability, time of blood draw and assay characteristics must be carefully considered. An orthogonal testing approach increases the accuracy of positive, but not negative, predictions." @default.
• W3094136275 created "2020-10-29" @default.
• W3094136275 creator A5001151283 @default.
• W3094136275 creator A5006353290 @default.
• W3094136275 creator A5020708921 @default.
• W3094136275 creator A5026815801 @default.
• W3094136275 creator A5026846457 @default.
• W3094136275 creator A5030101128 @default.
• W3094136275 creator A5033177889 @default.
• W3094136275 creator A5042732930 @default.
• W3094136275 creator A5043952542 @default.
• W3094136275 creator A5052883101 @default.
• W3094136275 creator A5053003825 @default.
• W3094136275 creator A5065398070 @default.
• W3094136275 creator A5065738420 @default.
• W3094136275 creator A5076689872 @default.
• W3094136275 creator A5077178350 @default.
• W3094136275 creator A5080523158 @default.
• W3094136275 creator A5081030123 @default.
• W3094136275 creator A5084754410 @default.
• W3094136275 creator A5086815077 @default.
• W3094136275 creator A5088324762 @default.
• W3094136275 creator A5090733610 @default.
• W3094136275 creator A5091458689 @default.
• W3094136275 date "2020-10-20" @default.
• W3094136275 modified "2023-10-08" @default.
• W3094136275 title "Temporal course of SARS-CoV-2 antibody positivity in patients with COVID-19 following the first clinical presentation" @default.
• W3094136275 cites W1991771021 @default.
• W3094136275 cites W3001897055 @default.
• W3094136275 cites W3009898265 @default.
• W3094136275 cites W3010719113 @default.
• W3094136275 cites W3013013352 @default.
• W3094136275 cites W3014249391 @default.
• W3094136275 cites W3022920345 @default.
• W3094136275 cites W3024506939 @default.
• W3094136275 cites W3024554369 @default.
• W3094136275 cites W3028034031 @default.
• W3094136275 cites W3030877763 @default.
• W3094136275 cites W3033069466 @default.
• W3094136275 cites W3033484283 @default.
• W3094136275 cites W3036159996 @default.
• W3094136275 cites W3038174280 @default.
• W3094136275 cites W3042215172 @default.
• W3094136275 cites W3043191821 @default.
• W3094136275 cites W3045845702 @default.
• W3094136275 cites W3092512024 @default.
• W3094136275 cites W4205829018 @default.
• W3094136275 cites W4206041650 @default.
• W3094136275 doi "https://doi.org/10.1101/2020.10.17.20214445" @default.
• W3094136275 hasPublicationYear "2020" @default.
• W3094136275 type Work @default.
• W3094136275 sameAs 3094136275 @default.
• W3094136275 citedByCount "3" @default.
• W3094136275 countsByYear W30941362752020 @default.
• W3094136275 countsByYear W30941362752021 @default.
• W3094136275 countsByYear W30941362752023 @default.
• W3094136275 crossrefType "posted-content" @default.
• W3094136275 hasAuthorship W3094136275A5001151283 @default.
• W3094136275 hasAuthorship W3094136275A5006353290 @default.
• W3094136275 hasAuthorship W3094136275A5020708921 @default.
• W3094136275 hasAuthorship W3094136275A5026815801 @default.
• W3094136275 hasAuthorship W3094136275A5026846457 @default.
• W3094136275 hasAuthorship W3094136275A5030101128 @default.
• W3094136275 hasAuthorship W3094136275A5033177889 @default.
• W3094136275 hasAuthorship W3094136275A5042732930 @default.
• W3094136275 hasAuthorship W3094136275A5043952542 @default.
• W3094136275 hasAuthorship W3094136275A5052883101 @default.
• W3094136275 hasAuthorship W3094136275A5053003825 @default.
• W3094136275 hasAuthorship W3094136275A5065398070 @default.
• W3094136275 hasAuthorship W3094136275A5065738420 @default.
• W3094136275 hasAuthorship W3094136275A5076689872 @default.
• W3094136275 hasAuthorship W3094136275A5077178350 @default.
• W3094136275 hasAuthorship W3094136275A5080523158 @default.
• W3094136275 hasAuthorship W3094136275A5081030123 @default.
• W3094136275 hasAuthorship W3094136275A5084754410 @default.
• W3094136275 hasAuthorship W3094136275A5086815077 @default.
• W3094136275 hasAuthorship W3094136275A5088324762 @default.
• W3094136275 hasAuthorship W3094136275A5090733610 @default.
• W3094136275 hasAuthorship W3094136275A5091458689 @default.
• W3094136275 hasBestOaLocation W30941362751 @default.
• W3094136275 hasConcept C126322002 @default.
• W3094136275 hasConcept C145802702 @default.
• W3094136275 hasConcept C159047783 @default.
• W3094136275 hasConcept C159654299 @default.
• W3094136275 hasConcept C185592680 @default.
• W3094136275 hasConcept C203014093 @default.
• W3094136275 hasConcept C2779134260 @default.
• W3094136275 hasConcept C2780420688 @default.
• W3094136275 hasConcept C2994453816 @default.
• W3094136275 hasConcept C3007834351 @default.
• W3094136275 hasConcept C3008058167 @default.
• W3094136275 hasConcept C3019719930 @default.
• W3094136275 hasConcept C43617362 @default.
• W3094136275 hasConcept C45189115 @default.
• W3094136275 hasConcept C524204448 @default.
• W3094136275 hasConcept C71924100 @default.
• W3094136275 hasConceptScore W3094136275C126322002 @default.
• W3094136275 hasConceptScore W3094136275C145802702 @default.
• W3094136275 hasConceptScore W3094136275C159047783 @default.
• W3094136275 hasConceptScore W3094136275C159654299 @default.

• next